Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Dogecoin Falls More Than 3% In 24 hours

Over the past 24 hours, Dogecoin's (CRYPTO: DOGE) price has fallen 3.5% to $0.08. This is opposite to its positive trend over the past week where it has experienced a 2.0% gain, moving from $0.07 to its current price.
byBenzinga Insights
March 24, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Over the past 24 hours, Dogecoin’s (CRYPTO: DOGE) price has fallen 3.5% to $0.08. This is opposite to its positive trend over the past week where it has experienced a 2.0% gain, moving from $0.07 to its current price.

The chart below compares the price movement and volatility for Dogecoin over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.

price_chart

The trading volume for the coin has increased 8.0% over the past week, while the overall circulating supply of the coin has decreased 0.24%. The current market cap ranking for DOGE is #8 at $10.44 billion.

supply_and_vol

Powered by CoinGecko API

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Orchard Therapeutics Announced Swissmedic Validation of the Marketing Authorization Application for Libmeldy (atidarsagene autotemcel)

By Charles Gross
December 1, 8:10 AM
Orchard Therapeutics (NASDAQ: ORTX), a global gene therapy leader, today announced its marketing authorization application (MAA) for Libmeldy® (atidarsagene autotemcel) has been accepted for evaluation by the Swiss Agency for Therapeutic Products (Swissmedic) for the potential treatment of eligible patients with early-on

ORTX